JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response

Ann Hematol. 2023 May;102(5):1279-1280. doi: 10.1007/s00277-023-05187-5. Epub 2023 Mar 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Chronic Disease
  • Humans
  • Janus Kinase 2 / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
  • Leukemia, Myeloid*
  • Mutation
  • Polycythemia Vera* / diagnosis
  • Polycythemia Vera* / genetics

Substances

  • JAK2 protein, human
  • Janus Kinase 2